David R. Colman, director of the Montreal Neurological Institute and Hospital, passed away unexpectedly on June 1, 2011. Liliana Pedraza, who worked closely with David Colman for 18 years, reflects on her dear friend and mentor.
Read more »
Volume 6, Number 1
Back pain brings with it a host of problems — but brain damage? It’s quite possible that chronic back pain doesn’t just inflict agony, it also impairs cognitive function, and actually reduces grey matter, in certain parts of the brain. But a new study reports that alleviating the pain can reverse those brain changes.
Read more »
Volume 6, Number 1
On November 2, 2011, Brenda Milner will receive this year’s Pearl Meister Greengard Prize from Rockefeller University. The prize recognizes female scientists who have made exceptional contributions to biomedical science, a group that historically has not received appropriate recognition and acclaim.
Read more »
Volume 6, Number 1
Toronto financier Lawrence S. Bloomberg is a fervent believer that active health is a key to reversing North America’s sagging health. By teaming up with Manulife Financial, the McGill grad (MBA’65) has helped to create a $50,000 annual prize that recognizes research achievements in the area of active health.
Read more »
Volume 6, Number 1
What do Inuit, the Shipibo and Shawi peoples of the Peruvian forest and the Batwa Pygmies of Uganda have in common? They all depend on the land for their survival — and are therefore all especially susceptible to climate change.
Read more »
Volume 6, Number 1
The only definitive way to diagnose Alzheimer’s disease was the most invasive procedure imaginable: a post mortem analysis of brain tissue. Now, thanks to a new study conducted at the Research Institute of the McGill University Health Centre (RI-MUHC), it may be possible to diagnose the insidious disease using a simple blood test.
Read more »
Volume 6, Number 1
As a researcher at the Lady Davis Institute at the Jewish General Hospital, Raz is interested in deception and how people’s physiology is influenced by their expectations of what is about to happen. He recently led a survey of physicians and psychiatrists at Canadian medical schools and found that one in five respondents has administered or prescribed a placebo.
Read more »
Volume 6, Number 1
The Research Institute of the McGill University Health Centre (RIMUHC) is one of three winners in the 2011-2012 Fonds de la recherche en santé du Québec competition. The RI-MUHC won a four-year grant of $1.4M for innovative strategic development in developing personalized medicine.
Read more »
Volume 6, Number 1
For many elderly people, the transition from hospital ward to long-term-care facility can bring with it resignation, even depression — but what happens when this important life change is drawn out over multiple moves?
Read more »
Volume 5, Number 1
McGill researchers are exploring whether fenretinide, a drug mostly used in cancer researcher, could reduce the severity of pulmonary infections related to cystic fibrosis—which could radically improve the lives of the 70,000 people diagnosed with CF worldwide.
Read The Article »
